Tessa Andermann, MD, MPH (she/her/hers)

Assistant Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

Dr. Andermann is an Assistant Professor of Medicine in the Division of Immunocompromised Host Infectious Diseases at UNC Chapel Hill. The Andermann Lab integrates short-read shotgun metagenomic and long-read Nanopore sequencing to investigate the antimicrobial gut “resistome” and AMR-specific horizontal gene transfer events in the gut under antibiotic and chemotherapy/immunotherapy pressure. She aims to determine how antimicrobial resistance gene dynamics predict the risk of infectious complications of immune-suppressive therapy in patients with cancer.

Disclosure(s): Seres Therapeutics: Advisor/Consultant

Presentation(s):

• 25 - Blood and Guts: Microbiome Discoveries

  Monday, October 20, 2025
  10:30 AM - 11:45 AM US ET

• 74 - Clinical and Microbiology Outcomes of Bloodstream Infections (BSI) in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HCT) in a Randomized, Double-blind, Placebo-controlled Cohort 2 of a Phase 1b Study of SER-155, an Investigational Live Biotherapeutic

  Monday, October 20, 2025
  10:30 AM - 10:42 AM US ET

• 172 - Bug to Drug: Translating Mechanisms of Antimicrobial Resistance to Treatment of Challenging Infections

  Tuesday, October 21, 2025
  3:15 PM - 4:30 PM US ET